english version En
italian version It english version En german version De chinese version Zh korean version Ko romanian version Ro portuguese version Pt spanish version Es Japanese version Ja
Login Join for free
Popular Searches
Popular news More >
SEARCHING....
no results found

TEVA stock fundamentals - financials as reported

Financials As Reported

  • accession Number 0001193125-23-140697
  • accounts Receivable Net Current 3,435,000,000
  • accumulated Other Comprehensive Income Loss Net Of Tax --2,701,000,000
  • amendment Flag false
  • assets 43,456,000,000
  • assets Current 11,501,000,000
  • cash And Cash Equivalents At Carrying Value 2,143,000,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,176,000,000
  • cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect --658,000,000
  • cik 818,686
  • city Area Code +972 (3)
  • common Stock Par Or Stated Value Per Share 0.1
  • common Stock Shares Authorized 2,495,000,000
  • common Stock Shares Issued 1,226,000,000
  • comprehensive Income Net Of Tax --69,000,000
  • cost Of Goods And Services Sold 2,079,000,000
  • current Fiscal Year End Date --12-31
  • date Filed 2023-05-10
  • document Fiscal Period Focus Q1
  • document Fiscal Year Focus 2,023
  • document Period End Date 2023-03-31
  • document Transition Report false
  • document Type 10-Q
  • earnings Per Share Basic -0.18
  • earnings Per Share Diluted -0.18
  • entity Address Address Line 1 124 Dvora HaNevi’a St.
  • entity Address City Or Town Tel Aviv
  • entity Address Postal Zip Code 6,944,020
  • entity Central Index Key 818,686
  • entity Current Reporting Status Yes
  • entity Emerging Growth Company false
  • entity File Number 001-16174
  • entity Filer Category Large Accelerated Filer
  • entity Incorporation State Country Code L3
  • entity Interactive Data Current Yes
  • entity Name TEVA PHARMACEUTICAL INDUSTRIES LTD
  • entity Registrant Name TEVA PHARMACEUTICAL INDUSTRIES LIMITED
  • entity Shell Company false
  • entity Small Business false
  • entity Tax Identification Number 00-0000000
  • gross Profit 1,582,000,000
  • income Tax Expense Benefit --19,000,000
  • inventory Net 4,118,000,000
  • irs Number 0
  • liabilities 34,844,000,000
  • liabilities And Stockholders Equity 43,456,000,000
  • liabilities Current 10,411,000,000
  • liabilities Noncurrent 24,433,000,000
  • local Phone Number 914-8213
  • long Term Debt Current 1,000,000,000
  • net Cash Provided By Used In Financing Activities --706,000,000
  • net Cash Provided By Used In Investing Activities 181,000,000
  • net Cash Provided By Used In Operating Activities --145,000,000
  • net Income Loss --205,000,000
  • nonoperating Income Expense --260,000,000
  • operating Income Loss 2,000,000
  • operating Lease Liability Noncurrent 345,000,000
  • operating Lease Right Of Use Asset 420,000,000
  • other Assets Current 542,000,000
  • other Assets Noncurrent 450,000,000
  • other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax 120,000,000
  • other Liabilities Current 1,000,000,000
  • other Liabilities Noncurrent 3,869,000,000
  • payments For Proceeds From Other Investing Activities 1,000,000
  • payments To Acquire Businesses Net Of Cash Acquired 0
  • payments To Acquire Property Plant And Equipment 139,000,000
  • period End 1,680,220,800,000
  • period Start 1,672,531,200,000
  • proceeds From Payments For Other Financing Activities --5,000,000
  • property Plant And Equipment Net 5,751,000,000
  • repayments Of Long Term Debt 3,152,000,000
  • report Link https://www.sec.gov/Archives/edgar/data/818686/000119312523140697/d464631d10q_htm.xml
  • retained Earnings Accumulated Deficit --13,086,000,000
  • revenue From Contract With Customer Excluding Assessed Tax 3,661,000,000
  • share Based Compensation 32,000,000
  • stockholders Equity 7,860,000,000
  • trading Symbol TEVA
  • update 1970-01-01
  • weighted Average Number Diluted Shares Outstanding Adjustment 1,115,000,000
  • weighted Average Number Of Diluted Shares Outstanding 1,115,000,000
  • weighted Average Number Of Shares Outstanding Basic 1,115,000,000
  • id REPORTED_FINANCIALS
  • key TEVA
  • subkey 10-Q
  • date 2023-05-10
  • updated 2023-05-11

Related News

News on the web

Teva (NYSE:TEVA) Delivers Q4 Beat; To Divest API Unit

469 Days ago TipRanks

Options Volatility and Implied Earnings Moves Today, January 31, 2024

469 Days ago TipRanks

Corcept (NASDAQ:CORT) Faces Setback in Patent Case; Shares Decline

498 Days ago TipRanks

HSBC Sees Opportunity in These 2 Biopharma Giants Ahead of the 2024 Elections

505 Days ago TipRanks

Teva Pharmaceutical (NYSE:TEVA) Says Business Unaffected by Israel-Palestine War

582 Days ago TipRanks

Here’s Why Teva Stock (NYSE:TEVA) Fell and Then Rose Yesterday

631 Days ago TipRanks
Trade Now
© Trading News. All Rights Reserved Since 2022